Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukast

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 73, Issue 6, 2005, Pages 453-462

  Şener, Göksel ^a   Şehirli, Özer ^a   Çetinel, Şule ^a   Ercan, Feriha ^a   Yüksel, Meral ^a   Gedik, Nursal ^a   Yeǧen, Berrak Ç ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; COLLAGEN; GLUTATHIONE; LACTATE DEHYDROGENASE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LUCIGENIN; LUMINOL; MALONALDEHYDE; MONTELUKAST; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DECAPITATION; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; ILEUM DISEASE; IMMUNOHISTOCHEMISTRY; LIGATION; LIPID PEROXIDATION; LIVER INJURY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUNCTURE; RAT; SEPSIS;

ACETATES; ANIMALS; CECUM; CHEMILUMINESCENT MEASUREMENTS; COLLAGEN; GLUTATHIONE; ILEAL DISEASES; ILEUM; L-LACTATE DEHYDROGENASE; LEUKOTRIENE ANTAGONISTS; LIGATION; LIVER; LIVER DISEASES; MALONDIALDEHYDE; PEROXIDASE; QUINOLINES; RATS; RATS, WISTAR; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 27644579586     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2005.07.008     Document Type: Article

References (48)

1. R.R. Neviere, G. Ceepinskas, W.S. Madorin, N. Hoque, M. Karmazyn, W.J. Sibbald, and P.R. Kvietys LPS pretreatment ameliorates peritonitis-induced myocardial inflammation and dysfunction: role of myocytes Am. J. Physiol. 277 1999 H885 H892
2. Z.M. Quezado, and C. Natanson Systemic hemodynamic abnormalities and vasopressor therapy in sepsis and septic shock Am. J. Kidney Dis. 20 1992 214 222
3. K. Bian, and F. Murad Diversity of endotoxin-induced nitrothyrosine formation in macrophage-endothelium-rich organs Free Radic. Biol. Med. 31 2001 421 429
4. R.J. Reiter, D. Acuna-Castroviejo, D.X. Tan, and S. Burkhardt Free radical-mediated molecular damage Ann. N. Y. Acad. Sci. 939 2001 200 215
5. C.C. Winterbourn, M.C. Vissers, and A.J. Kettle Myeloperoxidase Curr. Opin. Hematol. 7 2000 53 58
6. J.L. Wallace, W.K. MacNaughton, G.P. Morris, and P.L. Beck Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease Gastroenterology 96 1989 29 36
7. J.L. Wallace, P.L. Beck, and G.P. Morris Is there a role for leukotrienes as mediators of ethanol-induced gastric mucosal damage? Am. J. Physiol. 254 1988 G117 G123
8. J.L. Wallace, G.W. McKnight, C.M. Keenan, N.I. Byles, and W.K. MacNaughton Effects of leukotrienes on susceptibility of the rat stomach to damage and investigation of the mechanism of action Gastroenterology 98 1990 1178 1186
9. 4 synthesized by human alveolar macrophages Biochem. Biophys. Res. Commun. 111 1983 518 524
10. J.D. Williams, J.K. Czop, and K.F. Austen Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators J. Immunol. 132 1984 3034 3040
11. D. Aharony Pharmacology of leukotriene receptor antagonists Am. J. Respir. Crit. Care Med. 157 1998 S214 S219
12. P.M. O'Byrne Asthma treatment: antileukotriene drugs Can. Respir. J. 5 1998 64A 70A
13. B.M. Peskar Leukotrienes in mucosal damage and protection J. Physiol. Pharmacol. 42 1991 135 145
14. R. Holma, P. Salmenpera, A. Riutta, I. Virtanen, R. Korpela, and H. Vapaatalo Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats Eur. J. Pharmacol. 429 2001 309 318
15. N. Fujimura, S. Sumita, E. Narimatsu, Y. Nakayama, and Y. Shitinohe Effects of isoproterenol on diapragmatic contractility in septic peritonitis Am. J. Respir. Crit. Care Med. 161 2000 440 446
16. U. Haklar, M. Yuksel, A. Velioglu, M. Turkmen, G. Haklar, and A.S. Yalcin Oxygen radicals and nitric oxide levels in chondral or meniscal lesions or both Clin. Orthop. Relat. Res. 403 2002 135 142
17. J.A. Beuge, and S.D. Aust Microsomal lipid peroxidation Methods Enzymol. 52 1978 302 311
18. E. Beutler Glutathione in Red Blood Cell Metabolism. A Manuel of Biochemical Methods 1975 Grune & Stratton New York pp. 112-114
19. L.M. Hillegas, D.E. Griswold, B. Brickson, and C. Albrightson-Winslow Assesment of myeloperoxidase activity in whole rat kidney J. Pharmacol. Methods 24 1990 285 295
20. A. Lopez De Leon, and M. Rojkind A simple micromethod for collagen and total protein determination in formalin-fixed parraffin-embedded sections J. Histochem. Cytochem. 33 1985 737 743
21. F. Feihl, B. Waeber, and L. Liaudet Is nitric oxide overproduction the target of choice for the management of septic shock? Pharmacol. Ther. 91 2001 179 213
22. D.J. Wickel, W.G. Cheadle, M.A. Mercer-Jones, and R.N. Garrison Poor outcome from peritonitis is caused by disease acuity and organ failure, not recurrent peritoneal infection Ann. Surg. 225 1997 744 753
23. W.A. Knaus, E.A. Draper, D.P. Wagner, and J.E. Zimmerman Prognosis in acute organ-system failure Ann. Surg. 202 1985 685 693
24. H. Yang, H. Wang, T.R. Bernik, S. Ivanova, H. Wang, L. Ulloa, J. Roth, J.W. Eaton, and K.J. Tracey Globin attenuates the innate immune response to endotoxin Shock 17 2002 485 490
25. J.L. Swantek, M.F. Tsen, M.H. Cobb, and J.A. Thomas IL-1 receptor-associated kinase modulates host responsiveness to endotoxin J. Immunol. 164 2000 4301 4306
26. H.I. Lin, S.J. Chu, and D. Wang Pharmacological modulation of TNF production in macrophages J. Microbiol. Immunol. Infect. 37 2004 8 15
27. Q. Jiang, and B.N. Ames Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats FASEB J. 17 2003 816 822
28. J. Macdonald, H.F. Galley, and N.R. Webster Oxidative stress and gene expression in sepsis Br. J. Anaesth. 90 2003 221 232
29. G.M. Koksal, C. Sayilgan, S. Aydin, H. Oz, and H. Uzun Correlation of plasma and tissue oxidative stresses in intra-abdominal sepsis J. Surg. Res. 122 2004 180 183
30. K. Paskaloǧlu, G. Şener, C. Kapucu, and G. Ayanoglu-Dulger Melatonin treatment protects against sepsis-induced functional and biochemical changes in rat ileum and urinary bladder Life Sci. 74 2004 1093 1104
31. R.J. Reiter, D.X. Tan, C. Osuna, and E. Gitto Actions of melatonin in the reduction of oxidative stress J. Biomed. Sci. 7 2000 444 458
32. G.W. Sullivan, I.J. Sarembock, and J. Linden The role of inflammation in vascular diseases J. Leukocyte Biol. 67 2000 591 602
33. K.K. Donnahoo, X. Meng, A. Ayala, M.P. Cain, A.H. Harken, and D.R. Meldrum Early kidney TNF-α expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion Am. J. Physiol. 277 1999 R922 R929
34. S. Cuzzocrea, and R.J. Reiter Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury Eur. J. Pharmacol. 426 2001 1 10
35. B.J. Zimmerman, M.B. Grisham, and D.N. Granger Role of oxidants in ischemia-reperfusion induced granulocyte infiltration Am. J. Physiol. 258 1990 G185 G190
36. J.Y. Kim, and S.M. Lee Effect of ascorbic acid on hepatic vasoregulatory gene expression during polymicrobial sepsis Life Sci. 75 2004 2015 2026
37. M.B. Yerer, S. Aydoǧan, H. Yapişlar, O. Yalcin, O. Kuru, and O.K. Baskurt Melatonin increases glutathione peroxidase activity and deformability of erythrocytes in septic rats J. Pineal Res. 35 2003 138 139
38. R. Exner, B. Wessner, and N. Manhart Therapeutic potential of glutathione Wien. Klin. Wochenschr. 112 2000 610 616
39. D. Brealey, S. Karyampudi, T.S. Jacques, M. Novelli, R. Stidwill, V. Taylor, R.T. Smolenski, and M. Singer Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 2004 R491 R497
40. D.M. Guidot, and J. Roman Chronic ethanol ingestion increases susceptibility to acute lung injury: role of oxidative stress and tissue remodeling Chest 122 2002 309S 314S
41. H. Jefferies, J. Coster, and A. Khalil Glutathione Aust. N. Z. J. Surg. 73 2003 517 522
42. A. Jorg, W.R. Henderson, R.C. Murphy, and S.J. Klebanoff Leukotriene generation by eosiniphils J. Exp. Med. 155 1982 390 402
43. D.W. MacGlashan Jr., R.P. Schleimer, S.P. Peters, E.S. Schulman, G.K. Adams III, H.H. Newball, and L.M. Lichtenstein Generation of leukotrienes by purified human lung mast cells J. Clin. Invest. 70 1982 747 751
44. B.J. Morlion, E. Torwesten, K.S. Kuhn, C. Puchstein, and P. Furst Cysteinyl-leukotriene generation as a biomarker for survival in the critically ill Crit. Care Med. 28 2000 3655 3658
45. D. Aharony Pharmacology of leukotriene receptor antagonists Am. J. Respir. Crit. Care Med. 157 1998 S214 S219
46. E. Pizzichini, J.A. Leff, T.F. Reiss, L. Hendeles, L.P. Boulet, L.X. Wei, A.E. Efthimiadis, J. Zhang, and F.E. Hargreave Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial Eur. Respir. J. 14 1999 12 18
47. H.G. Struck, H. Geiser, H.U. Block, H.J. Mest, and M. Tost Leukotriene antagonist S 872419 A for early phase treatment of chemical burn in the rabbit eye Eur. J. Ophthalmol. 1 1991 137 141
48. G. Şener, L. Kabasakal, S. Cetinel, G. Contuk, N. Gedik, and B. Yegen Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs Burns 31 2005 587 596